Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 1.00 |
| ▸ | CA1 | P00915 | 7/20 | 1.00 |
| ▸ | CA2 | P00918 | 7/20 | 1.00 |
| ▸ | CA7 | P43166 | 7/20 | 1.00 |
| ▸ | CA9 | Q16790 | 7/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 7/20 | 1.00 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.70 |
| ▸ | ESR1 | P03372 | 2/20 | 0.63 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.63 |
| ▸ | XDH | P47989 | 1/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.55 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39791 | 1.00 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Water SCHEMBL16678551 | 0.98 | CA12 (0.96) | CA12CA1CA2CA7CA9 | |
| Alcohol SCHEMBL27942404 | 0.96 | CA12 (0.93) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1561197 | 0.89 | CA12 (0.79) | CA12CA1CA2CA7CA9 | |
| SCHEMBL190407 | 0.87 | CA12 (0.77) | CA12CA1CA2CA7CA9 | |
| SCHEMBL334524 | 0.87 | CA12 (0.77) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27935202 | 0.86 | CA12 (0.74) | CA12CA1CA2CA7CA9 | |
| SCHEMBL18309196 | 0.85 | CA1 (0.74) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3453843 | 0.85 | CA12 (0.74) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2904896 | 0.85 | CA12 (0.74) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115947669-B | Bionic synthesized amino acid surfactant and preparation method thereof | 成都初速率生物科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119438413-A | UPLC-MS chemical component of Zhuang medicine angelica sinensis and fingerprint analysis method thereof | 广西国际壮医医院 | 2025-02-14 | — | — | CN | claimed |
| CN-115838322-B | Polymerization inhibiting composition for olefin compounds and polymerization inhibiting method | 杭州唯铂莱生物科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-114232937-B | Environment-friendly super composite wear-resistant plate and preparation method thereof | 浙江冠峰新材料有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-115197507-B | Preparation method and application of polyvinyl chloride ultraviolet shielding additive | 安徽理工大学环境友好材料与职业健康研究院(芜湖) | 2023-11-14 | — | — | CN | claimed |
| US-20230293530-A1 | AGENTS FOR SENSITIZING SOLID TUMORS TO TREATMENT | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-09-21 | — | — | US | claimed |
| CN-116589750-A | Ultraviolet shielding composite material and preparation method and application thereof | 安徽理工大学 | 2023-08-15 | — | — | CN | claimed |
| CN-122059883-A | Production and preparation method of erlotinib intermediate | 安徽尖峰北卡药业有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122059965-A | Preparation method of Icotinib hydrochloride | 重庆圣华曦药业股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-115074425-B | Imaging reagent and kit for fluorescence-based multicycle nucleic acid sequencing reaction | 郑州思昆生物工程有限公司 | 2026-04-21 | — | — | CN | disclosed |
| US-20260102484-A1 | ADJUVANTS FOR ENHANCING THE IMMUNE RESPONSE | LANKENAU INSTITUTE FOR MEDICAL RESEARCH (US) | 2026-04-16 | — | — | US | disclosed |
| CN-115078315-B | Imaging reagent and kit for inhibiting decrease of fluorescence intensity | 郑州思昆生物工程有限公司 | 2025-12-26 | — | — | CN | disclosed |
| US-12472189-B2 | Treatment and prevention of capillary malformation-arteriovenous malformation | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-11-18 | — | — | US | disclosed |
| WO-2022192457-A1 | PREDICTING RESPONSE TO TREATMENTS IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA | BOSTONGENE CORPORATION (US) | 2022-09-15 | — | — | WO | disclosed |
| US-11426714-B2 | Metal organic frameworks (MOFs) and methods of synthesizing and using the same | VIETNAM NATIONAL UNIVERSITY HO CHI MINH CITY (VN) | 2022-08-30 | — | — | US | disclosed |
| EP-3320018-B1 | POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE | SHPP GLOBAL TECH BV (NL) | 2022-08-10 | — | — | EP | disclosed |
| WO-2022130211-A1 | FIRE RETARDANT POLYCARBONATE COMPOSITIONS FOR TRANSPARENT THIN‑WALL APPLICATIONS | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2022-06-23 | — | — | WO | disclosed |
| US-20220176011-A1 | SCAR REDUCING WOUND CLOSURE MATERIALS | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 2022-06-09 | — | — | US | disclosed |
| CN-108478790-B | Use of BT lipopeptides as therapeutic agents for obesity and related diseases | 星系有限公司 | 2022-05-31 | — | — | CN | disclosed |
| US-11337423-B1 | Candida auris disinfectant | JOHNSON LANNY LEO (US) | 2022-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12472189-B2 | Treatment and prevention of capillary malformation-arteriovenous malformation | EPHB4, EPHB1, EPHB3 | CA12 1781/4885CA1 3650/4885CA2 2752/4885 |
| US-20260102484-A1 | ADJUVANTS FOR ENHANCING THE IMMUNE RESPONSE | HIF1A, HIF1AN, EGLN3 | CA12 3375/4885CA1 2566/4885CA2 722/4885 |
| US-11337423-B1 | Candida auris disinfectant | CUTA, ERG28, ADH1A | CA12 168/4885CA1 260/4885CA2 2012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.